Results 11 to 20 of about 16,555 (256)

A pro-convulsive carbamazepine metabolite: Quinolinic acid in drug resistant epileptic human brain

open access: greenNeurobiology of Disease, 2012
Drugs and their metabolites often produce undesirable effects. These may be due to a number of mechanisms, including biotransformation by P450 enzymes which are not exclusively expressed by hepatocytes but also by endothelial cells in brain from ...
Chaitali Ghosh   +7 more
doaj   +2 more sources

Serum Kynurenine Pathway Metabolites as Candidate Diagnostic Biomarkers for Pituitary Adenoma: A Case–Control Study [PDF]

open access: yesMedicina
Background and Objectives: Pituitary adenomas are common intracranial tumors lacking specific non-invasive biomarkers. This study aimed to determine whether key metabolites and enzymes of the kynurenine pathway—including indoleamine 2,3-dioxygenase (IDO),
Nur Düzen Oflas   +3 more
doaj   +2 more sources

Plumbagin Alleviates Intracerebroventricular-Quinolinic Acid Induced Depression-like Behavior and Memory Deficits in Wistar Rats. [PDF]

open access: goldMolecules, 2022
Kumar Arora M   +9 more
europepmc   +3 more sources

QUINOLINIC ACID METABOLISM

open access: hybridJournal of Biological Chemistry, 1949
L.M. Henderson, G.B. Ramasarma
  +6 more sources

Crystal structure of N-[2-(cyclohexylsulfanyl)ethyl]quinolinic acid imide [PDF]

open access: yesActa Crystallographica Section E: Crystallographic Communications, 2017
The title compound, C15H18N2O2S {systematic name: 6-[2-(cyclohexylsulfanyl)ethyl]-5H-pyrrolo[3,4-b]pyridine-5,7(6H)-dione}, was obtained from the reaction of pyridine-2,3-dicarboxylic anhydride (synonym: quinolinic anhydride) with 2-(cyclohexylsulfanyl ...
Hyunjin Park   +3 more
doaj   +2 more sources

Adduct formed by chromium trioxide and zwitterionic quinolinic acid [PDF]

open access: goldOpen Chemistry, 2010
Sundberg Markku   +7 more
doaj   +2 more sources

Quinolinic acid and glutamatergic neurodegeneration in Caenorhabditis elegans. [PDF]

open access: greenNeurotoxicology, 2018
da Silveira TL   +8 more
europepmc   +3 more sources

Baseline multi‐omics signatures could predict therapeutic response to neoadjuvant anti‐PD‐1 immunochemotherapy in non‐small‐cell lung cancer

open access: yesClinical and Translational Medicine
Background Neoadjuvant anti‐programmed cell death 1 (PD‐1) immunochemotherapy has shown promising efficiency in the treatment of early‐stage non‐small‐cell lung cancer (NSCLC), but it has not consistently yielded durable responses.
Ailing Cao   +11 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy